Previous 10 | Next 10 |
NORTHVALE, NJ / ACCESSWIRE / April 20, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administrati...
Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Conference Call Feb 15, 2023, 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Robert Chen - Chief Financial Officer Conference Call Participants Presentation Ope...
Elite Pharmaceuticals press release ( OTCQB:ELTP ): Q3 GAAP EPS of $0.00. Revenue of $9.25M (+3.1% Y/Y). For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $9.25M
Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third qua...
Financials for Third Quarter Fiscal Year 2023 Ended December 31, 2022 will be released on February 14, 2023 NORTHVALE, NJ / ACCESSWIRE / February 8, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic product...
NORTHVALE, NJ / ACCESSWIRE / December 22, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administr...
Elite Pharmaceuticals press release ( OTCQB:ELTP ): FQ2 GAAP EPS of $0.00. Revenue of $8.59M (+0.4% Y/Y). As of September 30, 2022, and March 31, 2022, the Company had $0.41M and $0.41M, of restricted cash, respectively, related to debt service reserve in regard to th...
Elite Pharmaceuticals, Inc. (ELTP) Q2 2023 Earnings Conference Call November 15, 2022 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Robert Chen – Chief Financial Officer Conference Call Participants ...
Conference Call Scheduled for Tuesday, November 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the second ...
Financials for Second Quarter Fiscal Year 2023 Ended September 30, 2022 will be released on November 14, 2022 NORTHVALE, NJ / ACCESSWIRE / November 8, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic ...
News, Short Squeeze, Breakout and More Instantly...
Elite Pharmaceuticals Inc. Company Name:
ELTP Stock Symbol:
OTCMKTS Market:
Elite Pharmaceuticals Inc. Website:
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced to...